| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.031 | 0.3 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.031 | 0.3 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.05 | 0.3 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | -0.033 | 0.3 |